title: Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery disease.
authors.affiliation: Department of Cardiology, University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium.
authors.forename: Frans
authors.initials: F
authors.lastname: Van de Werf
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007097:Imines / Q000008:administration & dosage*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011725:Pyridines / Q000008:administration & dosage*
chemical_list: C540445:E 5555; D007097:Imines; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines